Sanofi (SNY) Change in Working Capital (2009 - 2026)

Sanofi has reported Change in Working Capital for 18 years, with the latest figure at $317.3 million in Q2 2026.

• Quarterly Change in Working Capital rose 38.78% year-over-year to $317.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.4 billion (up 180.22% YoY) and the FY2025 annual result came in at $317.8 million, up 337.33% from the prior year.
• Change in Working Capital improved to $317.3 million in Q2 2026 per SNY's latest filing, from -$406.2 million in the prior quarter.
• Over five years, Change in Working Capital peaked at $2.4 billion in Q4 2025 and troughed at -$2.6 billion in Q3 2024.
• A 5-year average of -$192.6 million and a median of -$101.0 million in 2025 frame the typical range for Change in Working Capital.
• The sharpest annual moves came in 2024 and 2025: Change in Working Capital plunged 343.26% in 2024, then surged 550.12% in 2025.
• Over 5 years, Change in Working Capital stood at -$1.1 billion in 2022, then soared by 119.67% to $222.7 million in 2023, then slumped by 343.26% to -$541.8 million in 2024, then soared by 550.12% to $2.4 billion in 2025, then slumped by 86.99% to $317.3 million in 2026.
• According to Business Quant data, Change in Working Capital over the past three periods registered $317.3 million, -$406.2 million, and $2.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.